Elevai Labs, Inc. (ELAB) Income Statement
ELAB 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsELAB revenue and net income
Where ELAB's revenue goes
2025Each bar shows an amount and its share of revenue. ELAB kept −1,306.3% of revenue as net income.
ELAB profit margins
ELAB growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −76.1% | −8.3% | — | — |
| Gross profit | −95.8% | −44.9% | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ELAB quarterly EPS vs estimates
Elevai Labs beat the analyst EPS estimate in 0 of the last 1 quarters. Next report: November 13, 2026.
ELAB income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $590,084 | $2.5M | $1.7M | $766,277 | $827 | $0 |
| Cost of revenue | $515,273 | $670,197 | $554 | $318,968 | $88 | — |
| Gross profit | $74,811 | $1.8M | −$554 | $447,309 | $739 | — |
| Research & development | $147,010 | $104,654 | $7,410 | $228,747 | $123,632 | $118,857 |
| Sales, general & admin | $1.6M | $855,764 | $3.4M | $1.7M | $634,334 | $102,987 |
| Total operating expenses | $7.5M | $3.7M | $1.1M | $2.2M | $785,801 | $221,844 |
| Operating income | −$7.4M | −$1.9M | −$1.1M | −$1.8M | −$785,062 | −$221,844 |
| Interest income | $118,030 | $12,891 | $5,564 | $7,702 | $0 | — |
| Interest expense | $547,128 | $735,197 | $19,525 | $2,629 | $0 | — |
| Income before taxes | −$7.7M | −$4.0M | −$1.7M | −$1.8M | −$784,739 | −$222,910 |
| Income taxes | $30,972 | — | $1 | −$2 | $3 | −$1,066 |
| Net income | −$7.7M | −$6.2M | −$4.3M | −$1.8M | −$784,739 | −$222,910 |
| EBITDA | −$7.3M | −$3.3M | −$1.1M | −$1.8M | −$781,982 | −$1,066 |
| EPS (diluted) | −$186225.67 | — | −$78576.99 | −$157.92 | — | — |
| Gross margin | 12.7% | 72.8% | −0.0% | 58.4% | 89.4% | — |
| Operating margin | −1,250.1% | −75.7% | −66.6% | −233.4% | −94,928.9% | — |
| Net margin | −1,306.3% | −253.1% | −251.2% | −234.9% | −94,889.8% | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $681,994 | $304,136 | $285,948 | $0 | $152,381 | $0 | $527,478 | $605,529 | $614,563 | $698,591 | $554,654 |
| Cost of revenue | $1.2M | $610,964 | $256,608 | $243,202 | $20 | $15,443 | $590,819 | $133,577 | $39,623 | $168,911 | $236,893 | $188,509 |
| Gross profit | $104,454 | $71,030 | $47,528 | $42,746 | −$20 | −$15,443 | −$1.7M | $393,901 | −$39,623 | $445,652 | $461,698 | $366,145 |
| Research & development | $310,219 | $47,061 | $32,902 | $15,000 | $66,675 | $32,433 | $164,132 | $95,260 | $15,082 | $103,194 | $122,474 | $86,374 |
| Sales, general & admin | $577,959 | $626,387 | $810,038 | $453,595 | $884,688 | $1.1M | $478,265 | $1.1M | $1.0M | $2.0M | $1.3M | $891,357 |
| Total operating expenses | $3.9M | $3.4M | $3.0M | $2.2M | $1.0M | $1.2M | −$2.1M | $1.3M | $516,431 | $2.1M | $1.5M | $366,145 |
| Operating income | −$3.8M | −$3.3M | −$3.0M | −$2.2M | −$1.0M | −$1.2M | $352,531 | −$919,837 | −$556,054 | −$1.7M | −$1.1M | −$788,664 |
| Interest income | $83,159 | $62,921 | $28,241 | $24,406 | $36,527 | $28,856 | $12,646 | $95 | $64 | $86 | $86 | $83 |
| Interest expense | $641,228 | $1.0M | $339,772 | $196,880 | $2 | $10,474 | $32,522 | $648,332 | $23,597 | $23,537 | $6,767 | $5,713 |
| Income before taxes | −$3.0M | −$5.0M | −$3.0M | −$2.6M | −$579,490 | −$1.6M | $294,284 | −$1.5M | −$552,911 | −$1.4M | −$1.2M | −$783,047 |
| Income taxes | — | −$3,662 | $30,972 | — | — | — | −$2 | — | −$2 | $2 | −$2 | $1 |
| Net income | −$2.9M | −$5.0M | −$3.0M | −$2.6M | −$562,355 | −$1.6M | −$1.9M | −$1.5M | −$1.4M | −$1.4M | −$1.2M | −$783,047 |
| EBITDA | −$3.5M | −$3.1M | −$2.9M | −$2.4M | −$579,467 | −$1.6M | $330,041 | −$852,925 | −$516,431 | −$1.4M | −$1.1M | −$774,422 |
| EPS (diluted) | −$0.61 | −$111.75 | −$519.17 | −$4.95 | −$8.44 | −$2.90 | — | −$94.85 | −$90777.00 | −$94818.36 | −$78576.99 | — |
| Gross margin | 8.0% | 10.4% | 15.6% | 14.9% | — | −10.1% | — | 74.7% | −6.5% | 72.5% | 66.1% | 66.0% |
| Operating margin | −292.2% | −487.0% | −975.3% | −767.5% | — | −788.4% | — | −174.4% | −91.8% | −273.9% | −153.8% | −142.2% |
| Net margin | −225.1% | −728.3% | −980.7% | −907.3% | — | −1,055.5% | — | −284.6% | −233.3% | −227.4% | −165.8% | −141.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ELAB's financial statements (latest annual report filed March 30, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ELAB financial results
In fiscal year 2025 (ended December 31, 2025), Elevai Labs reported revenue of $0.6 million, down 76.1% from the year before. It had a net loss of $7.7 million, a net profit margin of −1,306.3%. Diluted earnings per share came to −$186225.67.
See the ELAB stock overview for the latest quote and news, or the ELAB chart for price history and technical indicators.
ELAB income statement FAQ
What is Elevai Labs's annual revenue?
Elevai Labs reported total revenue of $0.6 million for fiscal year 2025, which ended on December 31, 2025. That was down 76.1% from $2.5 million the previous year.
Is Elevai Labs profitable?
No. Elevai Labs reported a net loss of $7.7 million in fiscal 2025, a net profit margin of −1,306.3%; its operating margin was −1,250.1%.
What is Elevai Labs's gross margin?
Elevai Labs's gross margin was 12.7% in fiscal 2025: for every $100 of revenue, Elevai Labs kept $13 after the direct cost of its products and services.
How much does Elevai Labs spend on research and development?
Elevai Labs spent $0.1 million on research and development in fiscal 2025, 24.9% of revenue.
What are Elevai Labs's earnings per share?
Elevai Labs earned $-186225.67 per diluted share in fiscal 2025.
When will Elevai Labs report its next earnings?
Elevai Labs is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
When does Elevai Labs's fiscal year end?
Elevai Labs's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 30, 2026.